San Diego, June 16, 2019 – IRISYS is pleased to announc …Continue Reading
Read more新闻发布
Director of Research and Development featured in Journal of Current Pharmaceutical Biotechnology
IRISYS is supportive of the continuing education of our …Continue Reading
Read moreBioCorRx Partners with IRISYS for Manufacturing of BICX102 Naltrexone Implant for Treatment of Opioid Use Disorder
San Diego, CA, February 26, 2019 – BioCorRx Inc. (OTCQB …Continue Reading
Read moreGerald Joseph Yakatan, PhD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who’s Who
– Dr. Yakatan has been endorsed by Marquis Who’s Who as …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Recognized as “International Cooperation Ambassador” for Life Science City in China
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRI …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Represents Biotech Industry at San Diego US-China Trade Relations Meeting
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRI …Continue Reading
Read moreIRISYS To Expand Drug Delivery Technology Capabilities & Services in China
– IRISYS Announces Joint Venture with Zhejiang Yangtze …Continue Reading
Read moreIRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder
IRISYS to discuss its customized services for international clients at the leading pharmaceutical industry event in China…
Read moreIRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference
Louis Scotti, Division President, will Showcase the SCOT-TUSSIN Sugar-free & Alcohol-free Medicines for Diabetic/Hypertensive Consumers…
Read moreIRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million
– Contract from the National Center for Advancing Trans …Continue Reading
Read moreIRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference
– More than 40 life sciences companies request meetings …Continue Reading
Read moreIRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference
– IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme
– Dr. Yakatan to Discuss: “Where Have All the New Drugs …Continue Reading
Read moreIRISYS Exhibits at Inaugural CPhI North America Conference
– Louis Scotti, Vice President, Business Development, l …Continue Reading
Read moreIRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value
– Award Increased to Up To $6,000,000 Over Five Years – …Continue Reading
Read moreIRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.
– Dr. Yakatan will hold meetings to discuss IRISYS’ cus …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum
– Dr. Yakatan joins discussions with executives from ph …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development
– Dr. Yakatan to Direct a Discussion with FDA CDER Lead …Continue Reading
Read moreIRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials
–Valued at Up To $3,000,000 Over Five Years – SAN DIEGO …Continue Reading
Read moreIRISYS Receives MetroConnect Award & California Competes Tax Credit
– Helps Support IRISYS Expansion Plans in San Diego and …Continue Reading
Read more